Biocon Ltd.
| BSE: 532523 |
Sector: Health care |
| NSE: BIOCON |
ISIN Code: INE376G01013 |
|
BSE
00:00 | 24 Apr 2020
|
Biocon Ltd
is not traded on BSE in the last 30 days
|
|
NSE
05:30 | 01 Jan 1970
|
Biocon Ltd
is not traded on NSE in the last 30 days
|
Notice: Undefined property: stdClass::$market_capital_for_nse in
/usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line
17
| OPEN |
342.05 |
| PREVIOUS CLOSE |
347.55 |
| VOLUME |
341566 |
| 52-Week high |
367.80 |
| 52-Week low |
211.30 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
356.30 |
| Buy Qty |
100.00 |
| Sell Price |
357.25 |
| Sell Qty |
51.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
367.80 |
| 52-Week low |
211.05 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
0 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
| OPEN |
342.05 |
| CLOSE |
347.55 |
| VOLUME |
341566 |
| 52-Week high |
367.80 |
| 52-Week low |
211.30 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
356.30 |
| Buy Qty |
100.00 |
| Sell Price |
357.25 |
| Sell Qty |
51.00 |
| OPEN |
|
| PREVIOUS CLOSE |
|
| VOLUME |
|
| 52-Week high |
367.80 |
| 52-Week low |
211.05 |
| P/E |
141.21 |
| Mkt Cap.(Rs cr) |
42,870 |
| Buy Price |
|
| Buy Qty |
|
| Sell Price |
|
| Sell Qty |
|
About Biocon Ltd.
Biocon Ltd
Biocon Limited is India's largest and fully-integrated innovation-led biopharmaceutical company. Some of its key brands are INSUGEN (rh-insulin) BASALOG (Glargine) CANMAb (Trastuzumab) BIOMAb-EGFR (Nimotuzumab) KRABEVAA (Bevacizumab) and ALZUMAb (Itolizumab) a 'first in class' anti-CD6 monoclonal antibody. The company has a rich pipeline of Biosimilars and Novel Biologics at various stages of deve...> More
Biocon Ltd - Key Fundamentals
Biocon Ltd - Financial Results
Particulars ( cr) |
Dec 2019 |
Dec 2018 |
% Chg |
| Net Sales |
1748.1 |
1540.8 |
13.45 |
| Other Income |
35.8 |
43.9 |
-18.45 |
| Total Income |
1783.9 |
1584.7 |
12.57 |
| Total Expenses |
1307.1 |
1160.1 |
12.67 |
| Operating Profit |
476.8 |
424.6 |
12.29 |
| Net Profit |
230.3 |
243.2 |
-5.3 |
| Equity Capital |
600 |
300 |
- |
> More on Biocon Ltd Financials Results
Biocon Ltd - SHAREHOLDING PATTERN
Biocon Ltd - Research Reports
Biocon Ltd - RETURNS
| Period |
BSE |
NSE |
Sensex |
NIFTY |
| 1 Week |
0.48% |
0.61% |
-0.83% |
-1.21% |
| 1 Month |
31.90% |
31.88% |
17.44% |
17.35% |
| 3 Month |
21.33% |
21.42% |
-24.72% |
-25.26% |
| 6 Month |
45.85% |
45.85% |
-19.72% |
-20.96% |
| 1 Year |
16.44% |
16.53% |
-19.79% |
-21.93% |
| 3 Year |
101.10% |
101.25% |
5.64% |
-0.69% |
Biocon Ltd - STOCK STRENGTH
| Today's Low/High |
339.45 |
|
359.85 |
| Week Low/High |
339.45 |
|
368.00 |
| Month Low/High |
254.40 |
|
368.00 |
| YEAR Low/High |
211.30 |
|
368.00 |
| All TIME Low/High |
14.42 |
|
368.00 |
cr)
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
Details
